Women's Health Innovation Summit 2021 | Kisaco Research

Women's Health Innovation Summit

Accelerating innovation, investment, research and partnerships, to improve the access and quality of healthcare for women worldwide.

Download 2021 Agenda
Boston USA / Virtual Day (Sept 28)
14-15 September, 2021

“This summit is a wonderful opportunity to learn about exciting innovations on the horizon and connect with potential collaborators in Women's Health.”

Allison Conti, Watkins-Conti Products

WHI 2021 STEERING COMMITTEE


WHY ATTEND?

Women’s Health is a critically underserved industry, with a plethora of unmet needs, under-researched diseases, and lack of innovative solutions and approaches.

The Women’s Health Innovation Summit is the sector’s leading platform committed to strengthening the network, tackling unmet needs and championing innovative approaches and solutions. Our focus is not only on female-only health challenges, but female-prevalent diseases and those conditions that affect or present differently in women.

With so many differing health challenges across a woman’s life, our flagship summit brings together all the critical stakeholders to focus on the intersections and sector-straddling challenges, with the ambition of ‘moving the needle’ toward improved outcomes in women’s health.

In 2021 these leadership discussions include:

  • Creating Opportunities for Investment and Scaling Women’s Health Start-Ups (Femtech).
  • Technological Advances and the Role of Digitization in advancing the sector.
  • The impact of COVID-19 on Women and Women’s Health, and the fall-out to come for the industry and the patient.
  • Latest Innovator’s & Entrepreneur Solutions showcased in our Women’s Health Innovation Spotlight.
  • Novel Care Models and Approaches; including moving to holistic, personalized or precision-based models.  
  • Access to Care and Treatment for Women in the USA.

Join our leading network of pharmaceuticals, biotech’s, medical device companies, start-ups, Femtech, insurers, CRO’s, investors, researchers, HCP’s and advocacy groups, to drive innovation at the convergence of healthcare and technology.

This year, the Women’s Health Innovation Summit will include both face-to-face and virtual components to reflect our global community. Attend in person on September 14-15 in Boston or join virtually on September 28 for high-level live discussions, on-demand content from across the series, and the opportunity to connect and have meetings with other attendees.

2021 Partners

Headline Partner

Associate Partner

KNOWLEDGE PARTNER

Event Partner

Media Partners

AUDIENCE BREAKDOWN

5%
Non-profits/ Advocacy Groups
10%
Investor/Funding Groups
8%
Payors/ Providers/ Employers
35%
Pharmaceutical Companies/ Medical Device & Diagnostics/Biotechs
30%
Start Ups/ Femtech/ Entrepreneurs/ Innovation
12%
Service Providers

Non-profits/ Advocacy Groups

Investor/Funding Groups

Payors/ Providers/ Employers

Pharmaceutical Companies/ Medical Device & Diagnostics/Biotechs

Start Ups/ Femtech/ Entrepreneurs/ Innovation

Service Providers

2021 Speakers

 

Alice Zheng, MD, MBA, MPH

Women’s Health Practice Leader
McKinsey & Company

Alice Zheng, MD, MBA, MPH

Women’s Health Practice Leader
McKinsey & Company

Alice Zheng, MD, MBA, MPH

Women’s Health Practice Leader
McKinsey & Company
 

Kathryn G. Schubert, MPP

President and CEO
Society of Women’s Heath Research

Kathryn G. Schubert, MPP

President and CEO
Society of Women’s Heath Research

Kathryn G. Schubert, MPP

President and CEO
Society of Women’s Heath Research
 

Marsha B. Henderson

Innovative Leader & Change Agent, Former Associate Commissioner for Women’s Health for FDA
Food and Drug Administration

Marsha B. Henderson is a nationally recognized innovative leader and change agent for the health of women and their families. As the former Associate Commissioner for Women’s Health at the Food and Drug Administration, for a decade, she progressed and managed cutting-edge policy, research and educational outreach initiatives.

Marsha B. Henderson

Innovative Leader & Change Agent, Former Associate Commissioner for Women’s Health for FDA
Food and Drug Administration

Marsha B. Henderson

Innovative Leader & Change Agent, Former Associate Commissioner for Women’s Health for FDA
Food and Drug Administration

Marsha B. Henderson is a nationally recognized innovative leader and change agent for the health of women and their families. As the former Associate Commissioner for Women’s Health at the Food and Drug Administration, for a decade, she progressed and managed cutting-edge policy, research and educational outreach initiatives. The Office of Women’s Health advanced its scientific efforts, under her direction, to produce more than 350 research papers and journal articles to facilitate FDA’s regulatory decision-making and promote a better understanding of sex differences and health conditions unique to women. Her tenure produced the first FDA Women’s’ Health Research Roadmap, outlining seven priority areas for new or enhanced research including biomarkers, nanotechnology, cardiovascular disease, and postmarket surveillance as well as a framework to assess its impact. Her colleagues applaud her ability to set a vision and guide the concept to reality. One FDA Commissioner stated, “She is elegant…not just in style but in character, confidence and compassion.”

 

Ms. Henderson’s expertise in the development of public-private partnerships and culturally appropriate consumer engagement strategies led to the Women’s Health Take Time To Care Program, which has reached over 120 million people with FDA consumer information in 18 languages, and received awards from more than 96 national organizations. Her easy to read, science-based materials have been chronicled in Dear Abby, Parade Magazine, Hints from Heloise, and the IRS, as well as sponsored by external groups including the National Association of Chain Drug Stores, American Diabetes Association, Ford Motor Company, American Medical Association, and even Las Vegas casinos. Her novel efforts supported a one-stop Pregnancy Exposure Registries website to gather information about how prescription drugs or vaccines affect a pregnant woman and her fetus. In addition, she recently instructed her staff to expand the Science of Sex and Gender on-line accredited courses with the NIH/Office of Research on Women’s Health and to conduct FDA’s first “Scientific Conference: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender” to address this national epidemic.

 

She is the recipient of numerous awards including the Dr. Estelle Ramey Award for Women’s Health Leadership from Society for Women’s Health Research; “HerMANA” Award for innovative outreach to Hispanic women, and Pinnacle Award for exceptional leadership in medication use for patients and caregivers.  The first non-pharmacist to receive the prestigious Jacob Miller Award from the American Pharmacists Association Foundation, she was also one of five Samuel J. Heyman Service to America Medal (Sammies) finalists from throughout the U.S. federal government. And as Chair of the national board of the YWCA USA, she led the U.S. delegation at the YWCA World Council quadrennial meeting in Bangkok, Thailand to focus on women’s issues.

Prior to her FDA career, Ms. Henderson served as the Director of Evaluation for the Interagency Council on the Homeless; Director of Placement for the National Health Service Corps; Chief of Analysis and Information for the Bureau of Maternal and Child Health; and Senior Advisor to the Director of the Women's Bureau at the U.S. Department of Labor.  Ms. Henderson earned a master’s degree from Rutgers University in health and hospital planning.  She is married to Wade Henderson, an internationally renowned civil and human rights lawyer.

 

Hadine Joffe

Executive Director
Mary Horrigan Conners Center for Women’s Health and Gender Biology, Brigham and Women’s Hospital

Hadine Joffe

Executive Director
Mary Horrigan Conners Center for Women’s Health and Gender Biology, Brigham and Women’s Hospital

Hadine Joffe

Executive Director
Mary Horrigan Conners Center for Women’s Health and Gender Biology, Brigham and Women’s Hospital
 

Christine Lemke

Co-founder, Co-Chief Executive Officer, & President
Evidation

Christine Lemke

Co-founder, Co-Chief Executive Officer, & President
Evidation

Christine Lemke

Co-founder, Co-Chief Executive Officer, & President
Evidation
 

Temitayo Erogbogbo

Global Advocacy Director
MSD for Mothers

Temitayo Erogbogbo

Global Advocacy Director
MSD for Mothers

Temitayo Erogbogbo

Global Advocacy Director
MSD for Mothers
 

Beth Battaglino

CEO
HealthyWomen

Beth Battaglino

CEO
HealthyWomen

Beth Battaglino

CEO
HealthyWomen
 

Dr. Nieca Goldberg

Medical Director, Joan H. Tisch Center for Women’s Health
NYU Langone

Dr. Nieca Goldberg

Medical Director, Joan H. Tisch Center for Women’s Health
NYU Langone

Dr. Nieca Goldberg

Medical Director, Joan H. Tisch Center for Women’s Health
NYU Langone
 

Tracy Warren

Managing Partner
Astarte Ventures

Tracy Warren

Managing Partner
Astarte Ventures

Tracy Warren

Managing Partner
Astarte Ventures
 

Tenesha Duncan

Principal, Maternal Health
Tara Health Foundation

Tenesha Duncan

Principal, Maternal Health
Tara Health Foundation

Tenesha Duncan

Principal, Maternal Health
Tara Health Foundation
 

Cheryl Kerr

Senior Director Strategy & Portfolio Management Women’s Health
Bayer

Cheryl Kerr

Senior Director Strategy & Portfolio Management Women’s Health
Bayer

Cheryl Kerr

Senior Director Strategy & Portfolio Management Women’s Health
Bayer
 

Erica Kantor

Medical Sector Manager
Sagentia

Erica Kantor

Medical Sector Manager
Sagentia

Erica Kantor

Medical Sector Manager
Sagentia
 

Susan C. Nicholson, MD, FIDSA

Vice President, Women’s Health
Johnson & Johnson

Susan C. Nicholson, MD, FIDSA

Vice President, Women’s Health
Johnson & Johnson

Susan C. Nicholson, MD, FIDSA

Vice President, Women’s Health
Johnson & Johnson
 

Jarrad Aguirre, MD, MBA

Head of Strategic Partnerships & Innovation
Myovant Sciences

Jarrad Aguirre, MD, MBA, is Head of Corporate Strategy and Advocacy at Myovant Sciences, a healthcare company focused on women's health and prostate cancer. In this role, he oversees corporate communications, patient advocacy, and digital strategy, and serves on the Executive Committee. 
 

Jarrad Aguirre, MD, MBA

Head of Strategic Partnerships & Innovation
Myovant Sciences

Jarrad Aguirre, MD, MBA

Head of Strategic Partnerships & Innovation
Myovant Sciences

Jarrad Aguirre, MD, MBA, is Head of Corporate Strategy and Advocacy at Myovant Sciences, a healthcare company focused on women's health and prostate cancer. In this role, he oversees corporate communications, patient advocacy, and digital strategy, and serves on the Executive Committee. 
 
Prior to joining Myovant, Jarrad worked as a physician, researcher, and consultant across the spectrum of health and healthcare, including at Brigham and Women's Hospital (a teaching hospital of Harvard Medical School), The Colorado Health Foundation, the Bill & Melinda Gates Foundation, and Collective Health. 
 
He graduated with honors from Yale University and University of Oxford, where he studied as a Rhodes Scholar. He completed the MD/MBA at Stanford University, supported by the Jack Kent Cooke Foundation Graduate Scholarship.  

 

 

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures
 

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)
 

Deirdre Albertson

Vice President, Project Management, Cardiovascular, Metabolic and Women’s Health
ICON

Deirdre Albertson

Vice President, Project Management, Cardiovascular, Metabolic and Women’s Health
ICON

Deirdre Albertson

Vice President, Project Management, Cardiovascular, Metabolic and Women’s Health
ICON
 

Lauren Demosthenes

Senior Medical Director
Babyscripts

Lauren Demosthenes

Senior Medical Director
Babyscripts

Lauren Demosthenes

Senior Medical Director
Babyscripts
 

Georgie Kovacs

Founder & CEO
Fempower Health

Georgie Kovacs

Founder & CEO
Fempower Health

Georgie Kovacs

Founder & CEO
Fempower Health
 

Juan Camilo Arjona Ferreira

, MD Chief Medical Officer
Myovant

Juan Camilo Arjona Ferreira

, MD Chief Medical Officer
Myovant

Juan Camilo Arjona Ferreira

, MD Chief Medical Officer
Myovant
 

Missy Lavender

CEO
Renalis Health

Missy Lavender

CEO
Renalis Health

Missy Lavender

CEO
Renalis Health
 

Dr. Barb DePree

Director of Holland Hospital, Women's Health
Holland Hospital

Dr. Barb DePree

Director of Holland Hospital, Women's Health
Holland Hospital

Dr. Barb DePree

Director of Holland Hospital, Women's Health
Holland Hospital
 

Susan Trent

CEO
Atlantic Therapeutics

Susan Trent, CEO, joined Atlantic Therapeutics in December 2019, leading the successful DTC launch of INNOVO® in the US and quickly demonstrating the scale-up potential of the brand. Prior to Atlantic Therapeutics, Susan spent 20+ years at GSK, building deep Pharmaceutical and Consumer Healthcare experience including the switch and transformation of Rx products into high-growth direct-to-consumer brands in weight control, smoking control, and skincare. Multi-market General Management, Marketing and BD leadership roles across Europe, US and Asia.

Susan Trent

CEO
Atlantic Therapeutics

Susan Trent

CEO
Atlantic Therapeutics

Susan Trent, CEO, joined Atlantic Therapeutics in December 2019, leading the successful DTC launch of INNOVO® in the US and quickly demonstrating the scale-up potential of the brand. Prior to Atlantic Therapeutics, Susan spent 20+ years at GSK, building deep Pharmaceutical and Consumer Healthcare experience including the switch and transformation of Rx products into high-growth direct-to-consumer brands in weight control, smoking control, and skincare. Multi-market General Management, Marketing and BD leadership roles across Europe, US and Asia.

 

Steven Gregg

Executive Director
The National Association of Continence

Steven Gregg

Executive Director
The National Association of Continence

Steven Gregg

Executive Director
The National Association of Continence
 

Reenita Das

Partner
Frost & Sullivan

Reenita Das

Partner
Frost & Sullivan

Reenita Das

Partner
Frost & Sullivan
 

Eric Dy

Founder and CEO
Bloomlife

Eric Dy

Founder and CEO
Bloomlife

Eric Dy

Founder and CEO
Bloomlife
 

Farida Peters-Abbadi

President & Chief Commercial Officer
Mirvie

Farida Peters-Abbadi

President & Chief Commercial Officer
Mirvie

Farida Peters-Abbadi

President & Chief Commercial Officer
Mirvie
 

Omar Dawood

Chief Medical Officer
Calm

Omar Dawood

Chief Medical Officer
Calm

Omar Dawood

Chief Medical Officer
Calm
 

Liz Klinger

CEO
Lioness

Liz Klinger

CEO
Lioness

Liz Klinger

CEO
Lioness
 

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth
 

Christine Henningsgaard

CEO & Co-Founder
Quilted Health

Christine Henningsgaard

CEO & Co-Founder
Quilted Health

Christine Henningsgaard

CEO & Co-Founder
Quilted Health
 

Amanda French

CEO
EMME

Amanda French

CEO
EMME

Amanda French

CEO
EMME
 

Marta Hill Gray

Executive Director
Gray Matter Group

Marta Hill Gray

Executive Director
Gray Matter Group

Marta Hill Gray

Executive Director
Gray Matter Group
 

Nathanial DeNicola

Head Telehealth Committee
ACOG

Nathanial DeNicola

Head Telehealth Committee
ACOG

Nathanial DeNicola

Head Telehealth Committee
ACOG
 

Mary Gunn

COO
Health Decisions

Mary Gunn

COO
Health Decisions

Mary Gunn

COO
Health Decisions
 

Tania Small

Vice President, Global Medical Oncology Franchise Head
GSK

Tania Small

Vice President, Global Medical Oncology Franchise Head
GSK

Tania Small

Vice President, Global Medical Oncology Franchise Head
GSK
 

Ally Crays

Youth Advisory Council Chair
PERIOD

Ally Crays

Youth Advisory Council Chair
PERIOD

Ally Crays

Youth Advisory Council Chair
PERIOD
 

Luba Greewood

Co-Founder & Board Member
LUCA Biologics

Luba Greewood

Co-Founder & Board Member
LUCA Biologics

Luba Greewood

Co-Founder & Board Member
LUCA Biologics
 

Rich Jones

EVP & Executive Director
Heritage Cares

Rich Jones

EVP & Executive Director
Heritage Cares

Rich Jones

EVP & Executive Director
Heritage Cares
 

Michela Bedard

Executive Director
PERIOD

Michela Bedard

Executive Director
PERIOD

Michela Bedard

Executive Director
PERIOD
 

Maggie Perracchio

RN BSN Director Population Health Clinical Program
Health New England

Maggie Perracchio

RN BSN Director Population Health Clinical Program
Health New England

Maggie Perracchio

RN BSN Director Population Health Clinical Program
Health New England
 

Nicole Leeds

Head of Marketing Strategy
Clue

Nicole Leeds

Head of Marketing Strategy
Clue

Nicole Leeds

Head of Marketing Strategy
Clue
 

Jannine Versi

COO & Co-Founder
Elektra Health

Jannine Versi

COO & Co-Founder
Elektra Health

Jannine Versi

COO & Co-Founder
Elektra Health

INNOVATION SPOTLIGHT 2021

The Women’s Health Innovation team are proud to announce the continuation of this prestigious ‘spotlight’ opportunity for the entrepreneurs and innovators in Women’s Health.

10 Finalists chosen by our Selection Committee, will present their company on both the Boston and virtual stage this September in a quick-fire round of presentations.

We are looking to hear 10 unique perspectives on the future of Women’s Health, and what your companies’ role is in that journey. Our platform is about giving a voice to the innovation that will ‘move the needle’ in Women’s Health and putting that in front of the decision-makers that can accelerate that vision.

We are seeking Femtech and Women’s Health companies providing a product, solution or service geared to helping women lead better lives. The application is stage agnostic and we are invested in the idea and ambition of the start-ups putting themselves forward.

Submission Deadline: July 30th. All applicants receive $100 off their ticket!

TOP TIP: The more detailed your application form, the more information the selection committee can use to make their decision. All applications are confidential and details will not be shared beyond the committee. However, if you do not wish to fill in a question, please feel free to leave it blank.

APPLY HERE

WHI Spotlight Innovation Selection Committee 2021

Author:

Elizabeth Bailey

Managing Director
Rhia Ventures

Author:

Maria Velissaris

Founding Partner
Steel Sky Ventures

Author:

Jessica Federer

Former- CDO at Bayer & Venture Partner
Boston Millennia Partners

Author:

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Download 2021 agenda

Please complete the form to access the 2021 Women's Health Innovation Summit (WHIS) Agenda.

Take a look at 2019 highlights:

Download the agenda for the Women's Health Innovation Summit 2021

Become a Partner

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

REGISTRATION

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

TICKET PRICES INCREASE IN

Monday, May 10, 2021 to Friday, November 19, 2021
Emerging - VIRTUAL ONLY
$499
For FemTech and Digital Health Companies, incl. Venture Capitalists and Angel Investors (with less than $10 million annual revenue)
Access to all virtual and on-demand content
1-2-1 video networking meetings
Access to content 2 months post event
Monday, May 10, 2021 to Friday, July 9, 2021
Emerging
$799
Super Early Bird rate until July 9th (Standard price $1199)
For FemTech and Digital Health Companies, incl. Venture Capitalists and Angel Investors (with less than $10 million annual revenue)
2 Day In-Person Conference Pass
Access to all virtual and on-demand content
In-Person networking opportunities and access to virtual networking platform
To increase your brand presence, contact Nathan Edwards: [email protected]
Monday, May 10, 2021 to Friday, November 19, 2021
Industry - VIRTUAL ONLY
$1099
For Pharma, Biotech, Medical Devices, Diagnostics, Multinational and Corporate (with over $10 million annual revenue)
Access to all virtual and on-demand content
1-2-1 video networking meetings
Access to content 2 months post event
Monday, May 10, 2021 to Friday, July 9, 2021
Industry
$1499
Super Early Bird rate until July 9th (Standard price $1999)
For Pharma, Biotech, Medical Devices, Diagnostics, Multinational and Corporate (with over $10 million annual revenue)
2 Day In-Person Conference Pass
Access to all virtual and on-demand content
In-Person networking opportunities and access to virtual networking platform
To increase your brand presence, contact Nathan Edwards: [email protected]
Monday, May 10, 2021 to Friday, November 19, 2021
Service Providers - VIRTUAL ONLY
$1299
For Consultants, Industry Vendors, Investment Banks and Private Equity Firms 
Access to all virtual and on-demand content
1-2-1 video networking video meetings
Access to content 2 months post event
Monday, May 10, 2021 to Friday, July 9, 2021
Service Providers
$1799
Super Early Bird rate until July 9th (Standard price $2199)
For Consultants, Industry Vendors, Investment Banks and Private Equity Firms 
2 Day In-Person Conference Pass
Access to all virtual and on-demand content
In-Person networking opportunities and access to virtual networking platform
To increase your brand presence, contact Nathan Edwards: [email protected]
Preparing registration...

Returning Safely Measures

Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.

All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.

Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.

Download the Kisaco Research Returning Safely Measures 

Venue

Venue

Hilton Boston Back Bay, 40 Dalton Street, Boston, MA, 02115


Book your room! 

Hilton Boston Back Bay

Arrival Date: 13-Sep-2021

Departure Date: 15-Sep-2021

Quote WOMENS HEALTH INNOVATION to book at the special group rate. 

Book here. 

 

 

 

 

RESOURCES

Download Resource

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Other events you might be interested in:

Women's Health Innovation Series: Women 40+ Innovation Summit